SERUM MANNAN-BINDING LECTIN IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C: ITS RELATION TO DISEASE PROGRESSION AND RESPONSE TO TREATMENT

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ESMAT SERAG; OMRAN DALIA; SLEEM GIHAN A.; RASHED LAILA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2012 | Volume:12 | Issue:4 Page(s): 259-264

Download Full-Text

View:

324

Download:

213

Cites:

Information Journal Paper

Title

SERUM MANNAN-BINDING LECTIN IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C: ITS RELATION TO DISEASE PROGRESSION AND RESPONSE TO TREATMENT

Author(s)

ESMAT SERAG | OMRAN DALIA | SLEEM GIHAN A. | RASHED LAILA | Issue Writer Certificate

Keywords

HEPATITIS C

INTERFERON

MANNAN

EGYPT

Abstract

Background: Chronic HEPATITIS C virus (HCV) infection is a major worldwide public health problem. EGYPT has the highest prevalence of adult HCV infection in the world, averaging 15%–25% in rural communities. MANNAN-binding lectin (MBL) is a liver-derived pluripotent serum lectin that plays a role in the innate immune system of the host. It is an acute-phase protein that is involved in the activation of the classical complement pathway. MBL may play a defensive role in HCV infection.Objectives: To investigate the relationship between MBL concentration and HCV infection in EGYPTian patients suffering chronic HEPATITIS C.Patients and Methods: Serum samples obtained from 35 EGYPTian HEPATITIS C patients and 30 normal controls were assayed for MBL. MBL concentrations were correlated to disease characteristics and treatment response.Results: Serum MBL was significantly higher in HCV patients than in controls, but no relationship was found between MBL concentration and disease progression in terms of hepatic fibrosis and inflammation. Responders to INTERFERON (INF) -based therapy had significantly higher serum MBL than non-responders.Conclusions: We found no association between serum MBL concentration and progression of HCV related liver disease. Responders to INF-based therapy had significantly higher serum MBL than non-responders.

Cites

No record.

References

No record.

Cite

APA: Copy

ESMAT, SERAG, OMRAN, DALIA, SLEEM, GIHAN A., & RASHED, LAILA. (2012). SERUM MANNAN-BINDING LECTIN IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C: ITS RELATION TO DISEASE PROGRESSION AND RESPONSE TO TREATMENT. HEPATITIS MONTHLY, 12(4), 259-264. SID. https://sid.ir/paper/306539/en

Vancouver: Copy

ESMAT SERAG, OMRAN DALIA, SLEEM GIHAN A., RASHED LAILA. SERUM MANNAN-BINDING LECTIN IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C: ITS RELATION TO DISEASE PROGRESSION AND RESPONSE TO TREATMENT. HEPATITIS MONTHLY[Internet]. 2012;12(4):259-264. Available from: https://sid.ir/paper/306539/en

IEEE: Copy

SERAG ESMAT, DALIA OMRAN, GIHAN A. SLEEM, and LAILA RASHED, “SERUM MANNAN-BINDING LECTIN IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C: ITS RELATION TO DISEASE PROGRESSION AND RESPONSE TO TREATMENT,” HEPATITIS MONTHLY, vol. 12, no. 4, pp. 259–264, 2012, [Online]. Available: https://sid.ir/paper/306539/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops